Trial Profile
A trial to assess bevacizumab, in combination with standard chemotherapy, in patients with metastatic colorectal cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Nov 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 23 Nov 2015 New trial record